MedPath

The Role of Neurofilament Light (NfL) in Patients With Hydrocephalus

Not Applicable
Recruiting
Conditions
Hydrocephalus
General Anesthetics Toxicity
Brain Damage
Interventions
Diagnostic Test: Lumbar puncture
Diagnostic Test: External lumbar drainage
Diagnostic Test: Lumbar infusion test
Procedure: Ventriculo-peritoneal shunt placement
Procedure: Blood sampling #3
Procedure: General Anesthesia
Procedure: Prechamber puncture
Procedure: Blood sampling #1
Procedure: Blood sampling #2
Procedure: Blood sampling #4 and #5
Registration Number
NCT05399602
Lead Sponsor
University Hospital Hradec Kralove
Brief Summary

Neurofilament Light Chain Protein (NfL) has been found by many studies as a sensitive biomarker of neuronal damage from several reasons, e.g. neurodegenerative diseases (Alzheimer's disease, Multiple Sclerosis, etc.), inflamation (HIV) or trauma. Its role as biomarker thus offers a possibility to predict and manage diseases associated with neuronal damage. Therefore our aim is to investigate the changes in level of NfL in hydrocephalus and to find its role in management of treatment in hydrocephalus.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
20
Inclusion Criteria
  • In group A:

    • Patients with diagnosed communicating hydrocephalus
    • MMSE > 10 points
    • Absence of any structural laesion on MRI or CT
    • Accepted Informed consent
  • In group B:

    • MMSE > 10 points
    • Absence of any structural laesion on MRI or CT
    • Accepted Informed consent
    • Elective spinal surgery without affecting dural sac and the spinal cord
    • Surgery shorter than 120 minutes of lasting the general anesthesia
Exclusion Criteria
  • Non-communicating hydrocephalus
  • Structural laesion on MRI or CT (tumour, contusion, aneurysm)
  • MMSE < 10 points
  • Life-expectancy shorter than 1 year
  • Pre-existing other type of demetia (m. Alzheimer, vascular dementia)
  • Surgery lasting more than 120 minutes
  • Blood loss more than 500 ml
  • Opening of dural sac (liquororhea)
  • Adverse events during general anestesia: MAP<60 mm Hg more than 5 minutes, arythmia with need for farmacological treatment

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Study group AGeneral AnesthesiaPatients with diagnosed hydrocephalus undergoing surgery (VP shunt placement) in general anestezia. Before surgery patients undergo lumbar puncture or external lumbar drainage placement to confirmate the diagnosis and responsivity to VP shunt placement.
Study group APrechamber puncturePatients with diagnosed hydrocephalus undergoing surgery (VP shunt placement) in general anestezia. Before surgery patients undergo lumbar puncture or external lumbar drainage placement to confirmate the diagnosis and responsivity to VP shunt placement.
Study group ABlood sampling #2Patients with diagnosed hydrocephalus undergoing surgery (VP shunt placement) in general anestezia. Before surgery patients undergo lumbar puncture or external lumbar drainage placement to confirmate the diagnosis and responsivity to VP shunt placement.
Study group BGeneral AnesthesiaPatients without diagnosed hydrocephalus undergoing short spinal surgery without affecting dural sac (e.g. anterior cervical discectomy and fusion or lumbar disc herniation or lumbar decompression) in general anestezia.
Study group ALumbar puncturePatients with diagnosed hydrocephalus undergoing surgery (VP shunt placement) in general anestezia. Before surgery patients undergo lumbar puncture or external lumbar drainage placement to confirmate the diagnosis and responsivity to VP shunt placement.
Study group AExternal lumbar drainagePatients with diagnosed hydrocephalus undergoing surgery (VP shunt placement) in general anestezia. Before surgery patients undergo lumbar puncture or external lumbar drainage placement to confirmate the diagnosis and responsivity to VP shunt placement.
Study group ALumbar infusion testPatients with diagnosed hydrocephalus undergoing surgery (VP shunt placement) in general anestezia. Before surgery patients undergo lumbar puncture or external lumbar drainage placement to confirmate the diagnosis and responsivity to VP shunt placement.
Study group AVentriculo-peritoneal shunt placementPatients with diagnosed hydrocephalus undergoing surgery (VP shunt placement) in general anestezia. Before surgery patients undergo lumbar puncture or external lumbar drainage placement to confirmate the diagnosis and responsivity to VP shunt placement.
Study group BBlood sampling #3Patients without diagnosed hydrocephalus undergoing short spinal surgery without affecting dural sac (e.g. anterior cervical discectomy and fusion or lumbar disc herniation or lumbar decompression) in general anestezia.
Study group ABlood sampling #1Patients with diagnosed hydrocephalus undergoing surgery (VP shunt placement) in general anestezia. Before surgery patients undergo lumbar puncture or external lumbar drainage placement to confirmate the diagnosis and responsivity to VP shunt placement.
Study group ABlood sampling #3Patients with diagnosed hydrocephalus undergoing surgery (VP shunt placement) in general anestezia. Before surgery patients undergo lumbar puncture or external lumbar drainage placement to confirmate the diagnosis and responsivity to VP shunt placement.
Study group BBlood sampling #1Patients without diagnosed hydrocephalus undergoing short spinal surgery without affecting dural sac (e.g. anterior cervical discectomy and fusion or lumbar disc herniation or lumbar decompression) in general anestezia.
Study group BBlood sampling #2Patients without diagnosed hydrocephalus undergoing short spinal surgery without affecting dural sac (e.g. anterior cervical discectomy and fusion or lumbar disc herniation or lumbar decompression) in general anestezia.
Study group ABlood sampling #4 and #5Patients with diagnosed hydrocephalus undergoing surgery (VP shunt placement) in general anestezia. Before surgery patients undergo lumbar puncture or external lumbar drainage placement to confirmate the diagnosis and responsivity to VP shunt placement.
Primary Outcome Measures
NameTimeMethod
Number of changes in valve settings3 months after surgery

To investigate the number of changes in valve settings according the patient's clinical state based on clinical examination, CT examination or telemetrically measured CSF pressure

Recruitment rate6 months

To assess the number of patients recruited in a pilot study. Recruitment rate is one of the predictor of feasibility of a study

Secondary Outcome Measures
NameTimeMethod
Correlation between NfL level and patient's clinical state3 months after surgery

To investigate in group A the correlation between the level of NfL get from CSF and blood sampling and observation in changes in patient's clinical state measured by mini-mental state examination (MMSE), 5-meter-walking test and patient's self-assessment questionare

Trial Locations

Locations (1)

University Hospital Hradec Kralove

🇨🇿

Hradec Králové, Czechia

© Copyright 2025. All Rights Reserved by MedPath